bcr-abl1 and the philadelphia chromosome - part 3: the bcr-abl fusion protein
Published 2 years ago • 9.9K plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
4:50
bcr-abl1 and the philadelphia chromosome - part 4: therapy of tumors with bcr-abl1 fusion proteins
-
3:13
bcr-abl1 and the philadelphia chromosome - part 2: the philadelphia chromosome
-
2:12
bcr-abl1 and the philadelphia chromosome - part 1: normal and aberrant karyograms
-
6:59
bcr-abl translocation mechanism | philadelphia chromosome
-
4:10
philadelphia chromosome [ph] - introduction, variants of bcr abl gene fusion & effects of variants
-
4:04
breaking bcr-abl resistance
-
1:06
allo-hsct in bcr-abl-negative mpn pretreated with jak inhibitors
-
4:15
new findings on the philadelphia chromosome
-
52:40
pursue 17 g (live): bcr-abl negative myeloproliferative neoplasms
-
1:05
feasibility of treatment cessation in patients with cml with atypical bcr-abl fusion transcripts
-
2:20
primary testicular and cutaneous philadelphia chromosome ph b-lbl - video abstract [id 353022]
-
4:31
managing toxicities from bcr-abl tkis in cml
-
5:41
bcr-abl1-targeted tkis in treatment of cml
-
5:52
philadelphia chromosome | chromosome 9 to 22 translocation | bcr-abl translocation| cml pathology
-
1:01
philadelphia chromosome:concepts simplified with the help of 2 markers. check out the main video.
-
6:08
combining and sequencing bcr-abl tkis with omacetaxine in cml
-
17:31
debate: chronic-phase cml patient develops a t315i mutation - experimental therapy
-
7:39
frontline treatment for cml with bcr-abl-targeted tkis
-
2:23
bcr-abl1 tkd mutation testing using ddpcr in a clinical hematology laboratory q&a: part 3